Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs vs Hyaluronic Acid in Knee Osteoarthritis
NCT04326985Phase 1Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2015
- Primary completion
- Jan 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of autologous mesenchymal stem cells in osteoarthritis (OA) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Knee Society Score at 1 year, Knee Society Function Score at 1 year and 1 more. Started Jan 2015; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04326985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04326985.